Another nationwide, retrospective, matched-cohort study in Taiwan found that a combination COX-2 inhibitors and metformin in OA patients with T2DM was associated with lower rates of joint replacement surgery than treatment with COX-2 inhibitors alone [133]. This evidence concerns the gene PTGS2 and type 2 diabetes mellitus.